Giulia C. Kennedy - 11 Nov 2022 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Role: Chief Scientific & Med Officer
Signature: /s/ Jonathan Wygant as attorney-in-fact
Issuer symbol: VCYT
Transactions as of: 11 Nov 2022
Net transactions value: -$30
Form type: 4
Filing time: 15 Nov 2022, 16:02:02 UTC
Previous filing: 08 Nov 2022
Next filing: 06 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VCYT	Common Stock	Options Exercise	$28.68	+2	+0%	$14.34	68,003	11 Nov 2022	Direct	F1
transaction	VCYT	Common Stock	Sale	$58.68	-2	-0%	$29.34	68,001	11 Nov 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VCYT	Stock Option (right to buy)	Options Exercise	$0	-2	-100%	$0.000000^*	0	11 Nov 2022	Common Stock	2	$14.34	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022.
F2	The option is fully vested.